Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2009-07-15 Investor Presentation
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Company Presentation June 2009
Investor Presentation Classification · 99% confidence The document is explicitly titled "Company Presentation June 2009" and contains slides, agenda points, corporate history, strategic focus areas (drug discovery, alliances), and forward-looking statements typical of an investor or shareholder presentation. It is not a formal regulatory filing like a 10-K, nor is it a short announcement of a report (RPA/RNS). It fits the definition of an Investor Presentation (IP). The date 'June 2009' confirms it is a specific presentation document.
2009-07-15 English
Evotec Q1 Summary 2009
Investor Presentation Classification · 95% confidence The document is titled "Evotec Q1 Summary 2009" and dated May 12, 2009. It contains an agenda listing "Financial Summary" and discusses operational performance, restructuring, and outlook. Crucially, it references the company's "most recent Annual Report on Form 20-F, filed with the Securities and Exchange Commission." The content structure (summary, highlights, agenda, detailed operational/financial building blocks) strongly suggests this is a presentation or summary released shortly after the end of the first quarter (Q1) to discuss performance. This aligns best with an Investor Presentation (IP) or potentially an Earnings Release (ER), but given the depth implied by the structure and the reference to the 20-F, it is most likely an Investor Presentation (IP) summarizing the period's results and strategy, rather than just the initial highlights (ER). It is not the full 10-K or a standalone Audit Report (AR). Since it is a detailed presentation summarizing the quarter, IP is the most appropriate classification.
2009-05-12 English
Q1 Report 2009
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Evotec AG, First Quarter Report 2009' and contains detailed financial statements, management discussion and analysis (MDA), and operational highlights for the first quarter of 2009. It provides comprehensive financial data, including revenue, operating loss, and cash flow analysis, which distinguishes it from a simple earnings release or a report publication announcement. It fits the definition of an Interim/Quarterly Report (IR). Q1 2009
2009-05-12 German
Corporate Presentation March 2009
Investor Presentation Classification · 95% confidence The document text contains several strong indicators: it explicitly mentions "FY 2008 results and strategy update," includes a detailed "Condensed Profit & Loss Statement (IFRS)" with comparative figures, discusses financial highlights, liquidity, R&D expenses, and outlines a strategic plan ("Evotec 2012 - Action Plan to Focus and Grow"). The presence of detailed financial tables and a review of the past fiscal year's performance strongly suggests a comprehensive annual review document. Although it references the "Annual Report on Form 20-F," the content itself appears to be an investor presentation or a management discussion summarizing the annual results, rather than the full regulatory 10-K filing. Given the structure (slides, agenda, highlights, strategy update) and the focus on summarizing the full year's performance and future strategy, it aligns best with an Investor Presentation (IP) or a Management Discussion & Analysis (MDA) summary. Since it contains detailed financial tables and management commentary on results and outlook, MDA is a strong fit, but Investor Presentation (IP) often encompasses this exact format (strategy update + financial summary presented to investors). Since the document is clearly a presentation summarizing the full year's results and strategy, Investor Presentation (IP) is the most appropriate classification over the comprehensive 10-K or the narrative-heavy MDA.
2009-04-07 English
Annual Report 2008
Annual Report Classification · 100% confidence The document is explicitly titled 'Evotec AG Annual Report 2008'. It contains comprehensive financial data, including consolidated financial statements (balance sheets, statements of operations, cash flows), management reports, and auditor's reports for the full fiscal year 2008. It meets all criteria for an Annual Report (10-K equivalent for a non-US entity). FY 2008
2009-03-30 German
Q3 Report 2008
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Evotec AG, Third Quarter Report 2008' and contains detailed financial statements, management discussion and analysis (MDA), operational highlights, and pipeline progress for the nine-month period ending September 30, 2008. It provides substantive financial data and analysis rather than just an announcement or certification. Therefore, it is classified as an Interim/Quarterly Report. 9M 2008
2008-11-14 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.